New ‘discreet’ Viagra Launched ending Embarrassment Of Blue Pill

The makers of Viagra are set to introduce a new ‘discrete’ type of the drug that will replace the iconic – and immediately recognisable – little blue tablet.

The distinctive diamond-shaped tablets could quickly be replaced by a pink, rectangular ‘wafer’ that dissolves on the tongue, indicating it does not need to be taken with water.

About half of males over 40 suffer erectile dysfunction in the UK and in 2015 there was a record 4.57 million prescriptions for Viagra on the NHS.

The drug initially pertained to the marketplace in the 1990s after being created by the American pharmaceutical business Pfizer.

It was first developed in the 1980s as a heart disease medication, but trial participants saw it had an unusual side impact – frequent erections.

Now, Pfizer spin-off Viatris, which owns the Viagra name and brand name, has actually applied for a trademark in the UK for the new form of the drug, Viagra ODF.

Viatris has currently launched the Viagra ODF in Canada and advertised it as being ‘thin and discreet’ which may be more suitable for numerous customers.

The distinctive tablets – which can cause shame for some clients – has been transformed and a brand-new dissolvable type may be available to Brits in the next 5 years. Stock image

‘Tablets are not constantly tolerable to patients and likewise sometimes the size of tablets may put patients off having them,’ Thorrun Govind, pharmacist and health professional, told The Telegraph.

She added: ‘Some men might still be finding the idea of having Viagr awkward, however I would hope that males’s health and conversations about sexual health have proceeded given that Viagra was very first formulated.’

Ms Govind thinks this brand-new design is a ‘positive advance’.

The new dissolvable medication is believed to most likely come to the UK imminently.

Rebecca Anderson-Smith, partner and chartered trade mark attorney at Mewburn Ellis, told the paper that the trademark application is a ‘great indicator’ it will be offered within the next 5 years.

She discussed trade mark registrations can be cancelled if they are not used for a continuous period of 5 years or more after registration. As an outcome, it appears Viatris means to release the product within the next few years.

However, approving a trademark would not guarantee the ODF might be sold and it would need to be authorized by the Medicines & Healthcare products Regulatory Agency first.

It’s expected to cost the very same as the tablet version and to be available in the very same doses.

A total of 4.57 million prescriptions for sildenafil, more known by the brand name Viagra, and other kinds of impotency drugs offered under the brand name names Cialis and Levitra, were dispensed by the health service in 2023

This comes after dodgy Viagra was discovered to be Britain’s most significant counterfeit drug after more than ₤ 6.2 million of fake blue tablet were taken by UK regulators in 2023.

More products of the erectile dysfunction drug were found than knock-off versions of painkillers like morphine.

Health officials said online retailers flouting policies were behind the fake supplies with most being imported from nations like India without a suitable licence.

Data, from UK regulator The Medicines and Healthcare products Regulatory Agency (MHRA), show 2.6 million doses of sildenafil, the generic name for the medication best known as Viagra, were seized last year.

Another half-million dosages of tadalafil, another erectile dysfunction drug sold under the brand name Cialis worth ₤ 1.2 million were also taken.

While all medications carry prospective side impacts drugs from unreliable sources might either not work or bring extra components or impurities like heavy metals or other drugs that could be harmful.